Partial shareholders of Shanghai Aladdin Biochemical Technology Co., Ltd. (688179.SH) plan to reduce their holdings in the company.
Aladdin (688179.SH) announced that due to the shareholders' own financial needs, shareholders Gu Weiyu, Wang Kun, Ling Qing, and Tan Xiaoyong plan to reduce their holdings of the company's shares through centralized bidding or block trading within 3 months after the disclosure date of the announcement, and within 15 trading days, under the premise of compliance with laws and regulations. The specific details are as follows:
Shanghai Aladdin Biochemical Technology Co., Ltd (688179.SH) announced that, due to their own capital needs, shareholders Gu Weiyu, Wang Kun, Ling Qing, and Tan Xiaoyong plan to reduce their holdings of the company's shares within 3 months from the date of the announcement, after the disclosure of the announcement for 15 trading days. The reduction will be done in compliance with legal and regulatory requirements, and through either centralized bidding or block trades. The specific details are as follows:
- Gu Weiyu plans to reduce the number of company shares by no more than 177,914 shares, representing 0.0491% of the total share capital of the company.
- Wang Kun plans to reduce the number of company shares by no more than 46,326 shares, representing 0.0128% of the total share capital of the company.
- Ling Qing plans to reduce the number of company shares by no more than 140,331 shares, representing 0.0388% of the total share capital of the company.
- Tan Xiaoyong plans to reduce the number of company shares by no more than 500,000 shares, representing 0.1381% of the total share capital of the company.
Related Articles

ETERNAL BEAUTY (06883) announces its annual performance, with a net profit of 2.43 billion yuan, an increase of 7.2% year-on-year.

SUNSHINE PHARMA (06887): Zhang Zhiyong selected as employee director.

E-STATION GTECH(08475): Ma Yongsheng will be appointed as the President of the subsidiary Qiansheng Shenzhen.
ETERNAL BEAUTY (06883) announces its annual performance, with a net profit of 2.43 billion yuan, an increase of 7.2% year-on-year.

SUNSHINE PHARMA (06887): Zhang Zhiyong selected as employee director.

E-STATION GTECH(08475): Ma Yongsheng will be appointed as the President of the subsidiary Qiansheng Shenzhen.

RECOMMEND





